Join the club for FREE to access the whole archive and other member benefits.

Rob Sambursky

Ophthalmologist and President of Verséa Health

Rob Sambursky currently serves as the President of Verséa Health since August 2022. Sambursky is a practicing, board-certified ophthalmologist with fellowship training in refractive surgery and corneal external and infectious disease. Previously, he worked at Visus Therapeutics, PPK Solutions, RPS Diagnostics, and Lumos Diagnostics, bringing over 20 years of scientific, clinical, and business experience. Rob also worked as a Cornea and Infectious Disease Specialist focusing on Cornea, Cataract, and Refractive Surgery at Coastal Eye Institute since July 2005.

He completed his medical internship at Harvard’s Mount Auburn Hospital and both his ophthalmology residency and cornea fellowship at Wills Eye Hospital in Philadelphia. He earned a BA degree in biology from Brown University, an MA degree in medical sciences with concentrations in biochemistry and microbiology from Boston University, and an MD degree from Boston University School of Medicine.


Visit website: https://www.versea.com/versea-holdings-welcomes-rob-sambursky-md-as-president/

 rob-sambursky-md-37a24721

See also: Company Versea Health - Life-science company to deliver innovative diagnostic and therapeutic solutions to improve health care

Details last updated 05-Aug-2023

Rob Sambursky News

Celularity and Versea Ophthalmics to commercialize ophthalmic allografts

Celularity and Versea Ophthalmics to commercialize ophthalmic allografts

Celularity - 27-Jul-2023

Innovative BIOVANCE single- and three-layer products for ocular surface disease treatment & surgical support